People who take the recently approved blood-thinning medication dabigatran could
have a slightly increased risk of heart
attack compared with people who use the old standby drug warfarin,
new research suggests.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
This is why, in my opinion, it is imperative that patients talk these medications over with their doctors and do some research on their own when they are prescribed any new medication that has come on the market. The problem with most new medications is that often the studies are limited and those drugs have not been tested over time. For many new drugs that come onto the market, we don't yet know what the long term effects might be. In my opinion, stick to the older medications that are proven and use has shown what their side effects and risks are. Coumadin (warfarin) has been around for decades and yes, regulating it requires blood work to regulate the dose. And, as with all medications that affect clotting, one has to use caution. Plus, the older medications usually come in generic form which makes them much less expensive.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |



